Search - tctmd.com

Displaying 761 - 780 of 1350

Sort: Relevancy | Date

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

News Industry News

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

October 14, 2015

News Conference News TCT 2015

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

October 14, 2015

News Industry News

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

October 14, 2015

News Industry News

Early Human Cases With Edwards FORMA Tricuspid Repair System Presented At TCT

October 14, 2015

News Conference News TCT 2015

Updates to CoreValve Extreme Risk Study Encouraging

October 13, 2015

News Industry News

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

October 13, 2015

News Conference News TCT 2015

Darbepoetin Plus Iron Fails to Reduce Transfusion Rates After TAVR in Anemia Patients

October 13, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

News Conference News TCT 2015

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

October 12, 2015

News Conference News TCT 2015

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

October 12, 2015

News Conference News TCT 2015

CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years

October 12, 2015

Presentation TCT 2015

Case Presentations/Taped TAVR Case Segments

Presenter: Samir R. Kapadia, Samir R. Kapadia, Ganesh Manoharan, Ian T. Meredith

October 11, 2015

News Conference News TCT 2015

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

October 11, 2015

News Conference News TCT 2015

Asian TAVR Registry Shows Good Procedural and Clinical Results

October 11, 2015

News Daily News

Reduced Leaflet Motion in Bioprosthetic Aortic Valves Not Uncommon But Remedied by Anticoagulation

L.A. McKeown

October 08, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Industry News

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

October 07, 2015

News Daily News

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

October 01, 2015

News Daily News

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

October 01, 2015

Advertisement

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

Early Human Cases With Edwards FORMA Tricuspid Repair System Presented At TCT

Updates to CoreValve Extreme Risk Study Encouraging

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

Darbepoetin Plus Iron Fails to Reduce Transfusion Rates After TAVR in Anemia Patients

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years

Case Presentations/Taped TAVR Case Segments

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

Asian TAVR Registry Shows Good Procedural and Clinical Results

Reduced Leaflet Motion in Bioprosthetic Aortic Valves Not Uncommon But Remedied by Anticoagulation

Boston Scientific Announces Scheduled Presentations At TCT 2015

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content